Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Non-small Cell Lung Cancer
In brief
This was a Phase III study of pembrolizumab plus platinum-based doublet chemotherapy with or without canakinumab in previously untreated locally advanced or metastatic non-squamous and squamous NSCLC participants.
Key facts
- Study ID
- NCT03631199
- Run by
- Novartis Pharmaceuticals
- People needed
- 673
- Starts
- 2018-12-21
- Expected to finish
- 2026-01-26
- Last updated by the study team
- 2026-06-17
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
Where it is running
- USC Kenneth Norris Comprehensive Cancer Center — Los Angeles, California, United States
- AdventHealth — Orlando, Florida, United States
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- Novartis Investigative Site — Caba, Buenos Aires, Argentina
- Novartis Investigative Site — Caba, Argentina
- Novartis Investigative Site — Westmead, New South Wales, Australia
- Novartis Investigative Site — Wooloongabba, Queensland, Australia
- Novartis Investigative Site — Melbourne, Victoria, Australia
- Novartis Investigative Site — Murdoch, Western Australia, Australia
- Novartis Investigative Site — Linz, Upper Austria, Austria
- Novartis Investigative Site — Salzburg, Austria
- Novartis Investigative Site — Barretos, São Paulo, Brazil
- Novartis Investigative Site — São Paulo, São Paulo, Brazil
- Novartis Investigative Site — São Paulo, São Paulo, Brazil
- Novartis Investigative Site — Edmonton, Alberta, Canada
- Novartis Investigative Site — Brampton, Ontario, Canada
- Novartis Investigative Site — Toronto, Ontario, Canada
- Novartis Investigative Site — Temuco, Araucania, Chile
- Novartis Investigative Site — Santiago, Chile
- Novartis Investigative Site — Harbin, Heilongjiang, China
- Novartis Investigative Site — Wuhan, Hubei, China
- Novartis Investigative Site — Wuhan, Hubei, China
- Novartis Investigative Site — Changsha, Hunan, China
- Novartis Investigative Site — Changchun, Jilin, China
- Pacific Shores Medical Group — Long Beach, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.